By Herbert Lash NEW YORK (Reuters) -A gauge of global stocks tumbled and Treasury yields shot up on Wednesday after the U.S. Federal Reserve projected another rate hike by year end and much tighter mo[...]
Read more
September 20, 2023
Disney CEO says company will ‘quiet the noise’ in culture wars -analyst
By Dawn Chmielewski (Reuters) -Walt Disney CEO Bob Iger told investors the company will “quiet the noise” in a culture war that has pitted social conservatives against the global media and[...]
Read more
AstraZeneca refused to pay full bonus to US remote worker, lawsuit claims
By Daniel Wiessner (Reuters) – AstraZeneca Pharmaceuticals LP has been sued in the U.S. by a former senior director who claims the drugmaker refused to pay her nearly $130,000 in promised bonuse[...]
Read more
Facing fares row, Ryanair hit by new antitrust probe in Italy
ROME (Reuters) -Italy’s antitrust agency opened an investigation on Wednesday into low-cost carrier Ryanair “for possible abuse of a dominant (market) position”, the latest regulator[...]
Read more
FTC nominees vow to combat deceptive AI practices
By Diane Bartz WASHINGTON (Reuters) – The deceptive use of artificial intelligence should be a priority for the Federal Trade Commission (FTC), three commissioner nominees said at a confirmation[...]
Read more
Dollar higher as Fed skips rate hike but stiffens hawkish stance
By Saqib Iqbal Ahmed NEW YORK (Reuters) -The U.S. dollar edged higher against a basket of currencies on Wednesday, after the Federal Reserve held interest rates steady but stiffened its hawkish stance[...]
Read more
Oil prices ease 1% after US Fed warns of higher rates for longer
By Scott DiSavino NEW YORK (Reuters) -Oil prices fell about 1% to a one-week low on Wednesday after the U.S. Federal Reserve left interest rates unchanged as widely expected, but stiffened its hawkish[...]
Read more
Cathie Wood’s ARK lands on European shores with Rize ETF acquisition
By Bansari Mayur Kamdar (Reuters) -Popular investor Cathie Wood is entering the European market with the acquisition of Rize ETF, but some investors are skeptical about the one-time pandemic darling[...]
Read more
Musk’s Neuralink to start human trial of brain implant for paralysis patients
(Reuters) -Billionaire entrepreneur Elon Musk’s brain-chip startup Neuralink said on Tuesday it has received approval from an independent review board to begin recruitment for the first human tr[...]
Read more